© 1989 Oxford University Press
research-article |
Epithelial Ovarian Cancer and Combined Oral Contraceptives
THE WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES
WHO Collaborative Study of Neoplasia and Steroid Contraceptives Epithelial Ovarian Cancer and combined oral contraceptives. International Journal of Epidemiology, 1989; 18: 538545.The relationship between use of combined oral contraceptives and risk of epithelial ovarian cancer was investigated in a hospital-based casecontrol study conducted from 19791986 in seven countries. Three hundred and sixtyeight women with histologically confirmed epithelial ovarian cancer were compared to 2397 hospital controls matched for age, study centre, hospital and year of interview. The relative risk (RR) in women who ever used combined oral contraceptives, controlling for the confounding effect of number of pregnancies, was 0.75 {95% confidence interval (CI) 0.56, 1.01). The relative risk decreased with increasing duration of oral contraceptive use and with increasing time since cessation of use. Except for mucinous tumours, oral contraceptive use was associated with lower risk of all histological subtypes of epithelial ovarian cancer. While the reduced risk associated with oral contraceptive use was present in parous women (RR = 0.85), it was most pronounced in nulliparous women (RR = 0.16). The magnitude of the negative association between oral contraceptives and ovarian cancer in five developing countries (RR = 0.77) was similar to that reported in developed countries.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. S. Tworoger, K. M. Fairfield, G. A. Colditz, B. A. Rosner, and S. E. Hankinson Association of Oral Contraceptive Use, Other Contraceptive Methods, and Infertility with Ovarian Cancer Risk Am. J. Epidemiol., October 15, 2007; 166(8): 894 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Soegaard, A. Jensen, E. Hogdall, L. Christensen, C. Hogdall, J. Blaakaer, and S. K. Kjaer Different Risk Factor Profiles for Mucinous and Nonmucinous Ovarian Cancer: Results from the Danish MALOVA Study Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1160 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Marquez, K. A. Baggerly, A. P. Patterson, J. Liu, R. Broaddus, M. Frumovitz, E. N. Atkinson, D. I. Smith, L. Hartmann, D. Fishman, et al. Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon Clin. Cancer Res., September 1, 2005; 11(17): 6116 - 6126. [Abstract] [Full Text] [PDF] |
||||
![]() |
ESHRE Capri Workshop Group Hormones and breast cancer Hum. Reprod. Update, July 1, 2004; 10(4): 281 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K Kjaer, L. Mellemkjaer, L. A Brinton, C. Johansen, G. Gridley, and J. H Olsen Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women Int. J. Epidemiol., June 1, 2004; 33(3): 596 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Tung, M. T. Goodman, A. H. Wu, K. McDuffie, L. R. Wilkens, L. N. Kolonel, A. M. Y. Nomura, K. Y. Terada, M. E. Carney, and L. H. Sobin Reproductive Factors and Epithelial Ovarian Cancer Risk by Histologic Type:A Multiethnic Case-Control Study Am. J. Epidemiol., October 1, 2003; 158(7): 629 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Riman, P. W. Dickman, S. Nilsson, N. Correia, H. Nordlinder, C. M. Magnusson, and I. R. Persson Risk Factors for Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control Study Am. J. Epidemiol., August 15, 2002; 156(4): 363 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Riman, P. W. Dickman, S. Nilsson, N. Correia, H. Nordlinder, C. M. Magnusson, E. Weiderpass, and I. R. Persson Hormone Replacement Therapy and the Risk of Invasive Epithelial Ovarian Cancer in Swedish Women J Natl Cancer Inst, April 3, 2002; 94(7): 497 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Rodriguez, N. P. Nagarsheth, K. L. Lee, R. C. Bentley, D. K. Walmer, M. Cline, R. S. Whitaker, P. Isner, A. Berchuck, R. K. Dodge, et al. Progestin-Induced Apoptosis in the Macaque Ovarian Epithelium: Differential Regulation of Transforming Growth Factor-{beta} J Natl Cancer Inst, January 2, 2002; 94(1): 50 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Purdie, V. Siskind, C. J. Bain, P. M. Webb, and A. C. Green Reproduction-related Risk Factors for Mucinous and Nonmucinous Epithelial Ovarian Cancer Am. J. Epidemiol., May 1, 2001; 153(9): 860 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Westhoff, J. A. Britton, M. D. Gammon, T. Wright, and J. L. Kelsey Oral Contraceptives and Benign Ovarian Tumors Am. J. Epidemiol., August 1, 2000; 152(3): 242 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Whiteman, M. F. G. Murphy, L. S. Cook, D. W. Cramer, P. Hartge, P. A. Marchbanks, P. C. Nasca, R. B. Ness, D. M. Purdie, and H. A. Risch Multiple Births and Risk of Epithelial Ovarian Cancer J Natl Cancer Inst, July 19, 2000; 92(14): 1172 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Ness and C. Cottreau Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer J Natl Cancer Inst, September 1, 1999; 91(17): 1459 - 1467. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Rodriguez, D. K. Walmer, M. Cline, H. Krigman, B. A. Lessey, R. S. Whitaker, R. Dodge, and C. L. Hughes Effect of Progestin on the Ovarian Epithelium of Macaques: Cancer Prevention Through Apoptosis? Reproductive Sciences, September 1, 1998; 5(5): 271 - 276. [Abstract] [PDF] |
||||






